Inventiva S.A. (EPA:IVA)
France · Delayed Price · Currency is EUR 5.70
-0.04 (-0.70%)
At close: Jan 28, 2026
Inventiva Market Cap
Inventiva has a market cap or net worth of €1.1 billion as of January 28, 2026. Its market cap has increased by 439.41% in one year.
Market Cap
1.10B
Enterprise Value
1.11B
Revenue
16.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.70
Market Cap Chart
Since February 15, 2017, Inventiva's market cap has increased from 134.55M to 1.10B, an increase of 714.99%. That is a compound annual growth rate of 26.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 1.10B | 45.50% |
| Dec 31, 2025 | 753.62M | 261.37% |
| Dec 31, 2024 | 208.54M | -1.39% |
| Dec 29, 2023 | 211.49M | 12.21% |
| Dec 30, 2022 | 188.49M | -60.71% |
| Dec 31, 2021 | 479.69M | 6.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 7.86B |
| DBV Technologies | 1.18B |
| MedinCell | 918.94M |
| Nanobiotix | 900.02M |
| Valneva SE | 708.58M |
| Genfit | 280.85M |
| Cellectis | 257.12M |
| Transgene | 251.92M |